0000795266-21-000123.txt : 20211015
0000795266-21-000123.hdr.sgml : 20211015
20211015164120
ACCESSION NUMBER: 0000795266-21-000123
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211013
FILED AS OF DATE: 20211015
DATE AS OF CHANGE: 20211015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilligan Thomas W.
CENTRAL INDEX KEY: 0001553750
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09195
FILM NUMBER: 211326441
MAIL ADDRESS:
STREET 1: C/O KB HOME
STREET 2: 10990 WILSHIRE BOULEVARD, 7TH FLOOR
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KB HOME
CENTRAL INDEX KEY: 0000795266
STANDARD INDUSTRIAL CLASSIFICATION: OPERATIVE BUILDERS [1531]
IRS NUMBER: 953666267
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1130
BUSINESS ADDRESS:
STREET 1: 10990 WILSHIRE BLVD
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
BUSINESS PHONE: 3102314000
MAIL ADDRESS:
STREET 1: 10990 WILSHIRE BLVD
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
FORMER COMPANY:
FORMER CONFORMED NAME: KAUFMAN & BROAD HOME CORP
DATE OF NAME CHANGE: 19920703
4
1
wf-form4_163433046775839.xml
FORM 4
X0306
4
2021-10-13
0
0000795266
KB HOME
KBH
0001553750
Gilligan Thomas W.
C/O KB HOME
10990 WILSHIRE BOULEVARD, 7TH FLOOR
LOS ANGELES
CA
90024
1
0
0
0
Common Stock
2021-10-13
4
M
0
10491
9.89
A
70488
D
Common Stock
2021-10-13
4
D
0
4136
39.13
D
66352
D
Common Stock
2021-10-13
4
M
0
7241
20.70
A
73593
D
Common Stock
2021-10-13
4
D
0
2855
39.13
D
70738
D
Common Stock
2021-10-13
4
M
0
9157
17.60
A
79895
D
Common Stock
2021-10-13
4
D
0
3610
39.13
D
76285
D
Common Stock
2021-10-14
4
S
0
35222
40.49
D
41063
D
Non-Qualified Stock Option (Right to Buy)
9.89
2021-10-13
4
M
0
10491
0
D
2013-07-18
2022-07-18
Common Stock
10491.0
0
D
Non-Qualified Stock Option (Right to Buy)
20.7
2021-10-13
4
M
0
7241
0
D
2014-04-04
2023-04-04
Common Stock
7241.0
0
D
Non-Qualified Stock Option (Right to Buy)
17.6
2021-10-13
4
M
0
9157
0
D
2015-04-03
2024-04-03
Common Stock
9157.0
0
D
Based on the reporting person's election, the reporting person received shares of the issuer's common stock equal in value to the positive difference between each exercised stock option's exercise price and the closing price of the issuer's common stock on the date of exercise. Accordingly, each exercised stock option was settled in a manner similar to a stock appreciation right. No shares of the issuer's common stock were sold in these transactions.
Tony Richelieu, Attorney-in-Fact for Thomas W. Gilligan
2021-10-15